Sleep

Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.

Sleep

Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M

Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.

Sleep

Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M

The young and the rest-less.

Sleep

Walsh CM, Poe GR

The young and the rest-less.

Sleep

Walsh CM, Poe GR

The consensus sleep diary: standardizing prospective sleep self-monitoring.

Sleep

Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, Morin CM

The consensus sleep diary: standardizing prospective sleep self-monitoring.

Sleep

Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, Morin CM

The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study.

Sleep

Low Y, Preud'homme X, Goforth HW, Omonuwa T, Krystal AD

The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study.

Sleep

Low Y, Preud'homme X, Goforth HW, Omonuwa T, Krystal AD

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Sleep

Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Sleep

Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T

Pages